Trial Profile
Phase I trial of a once-daily, biphasic formulation of remogliflozin etabonate in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs Remogliflozin etabonate (Primary) ; Remogliflozin etabonate
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Islet Sciences
- 14 Oct 2014 New trial record